BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33552934)

  • 21. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
    Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.
    Johnson DH; Turrisi AT; Chang AY; Blum R; Bonomi P; Ettinger D; Wagner H
    J Clin Oncol; 1993 May; 11(5):879-84. PubMed ID: 8387577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
    J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twice-daily vs higher-dose once-daily thoracic radiotherapy for limited-disease small-cell lung cancer: A PRISMA-compliant meta-analysis.
    Yang L; Liu L; Yang Y; Lei Y; Wang T; Wu X; Guo X
    Medicine (Baltimore); 2020 Jul; 99(27):e20518. PubMed ID: 32629632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy Fraction in Limited-Stage Small Cell Lung Cancer in the Modern Era: A Systematic Review and Meta-Analysis of 8006 Reconstructed Individual Patient Data.
    Zhao J; Wu L; Hu C; Bi N; Wang L
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
    Bogart J; Wang X; Masters G; Gao J; Komaki R; Gaspar LE; Heymach J; Bonner J; Kuzma C; Waqar S; Petty W; Stinchcombe TE; Bradley JD; Vokes E
    J Clin Oncol; 2023 May; 41(13):2394-2402. PubMed ID: 36623230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer].
    You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):55-60. PubMed ID: 28103974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer.
    Schild SE; Vokes EE
    Ann Oncol; 2016 Apr; 27(4):590-9. PubMed ID: 26712904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis.
    Palma DA; Warner A; Louie AV; Senan S; Slotman B; Rodrigues GB
    Clin Lung Cancer; 2016 Jul; 17(4):239-44. PubMed ID: 26498503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses.
    Hu X; Bao Y; Xu YJ; Zhu HN; Liu JS; Zhang L; Guo Y; Jin Y; Wang J; Ma HL; Xu XL; Song ZB; Tang HR; Peng F; Fang M; Kong Y; Chen MY; Dong BQ; Zhu L; Yu C; Yu XM; Hong W; Fan Y; Zhang YP; Chen PC; Zhao Q; Jiang YH; Zhou XM; Chen QX; Sun WY; Mao WM; Chen M
    Cancer; 2020 Feb; 126(4):840-849. PubMed ID: 31714592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent Etoposide/Cisplatin Combination Chemotherapy (EP) and Thoracic Radiotherapy after Two Cycles of EP for Limited Stage Small Cell Lung Cancer.
    Sohn HJ; Kim SW; Ahn JH; Kang HJ; Park S; Jung HN; Suh CW; Kim WK; Lee SW; Choi EK; Lee SD; Kim WS; Kim DS; Kim WD; Lee JS
    Cancer Res Treat; 2002 Dec; 34(6):409-15. PubMed ID: 26680896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
    Levin N; Killingberg KT; Halvorsen TO; Danielsen S; Grønberg BH
    Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38583494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
    Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative.
    Allen SG; Dragovic AF; Yin HM; Bryant AK; Paximadis PA; Matuszak MM; Schipper MJ; Dess RT; Hayman JA; Dominello MM; Kestin LL; Movsas B; Jolly S; Bergsma DP;
    Pract Radiat Oncol; 2023; 13(5):444-453. PubMed ID: 37100388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness and toxicity of radiotherapy regimens in limited stage small cell lung cancer: A network meta-analysis.
    Zhou J; Guo H; Zhang Y; Liu H; Dou Q
    Cancer Med; 2022 Nov; 11(22):4214-4224. PubMed ID: 35466552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer.
    Halvorsen TO; Valan CD; Slaaen M; Grønberg BH
    J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1283-1290. PubMed ID: 32725772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of thoracic radiation therapy after chemotherapy on survival in extensive-stage small cell lung cancer: A propensity score-matched analysis.
    Deng L; Zhou Z; Xiao Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Bi N; Wang X; Zhang T; Wang W; Wang L
    Thorac Cancer; 2019 Apr; 10(4):799-806. PubMed ID: 30779334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited-disease small-cell lung cancer.
    Lu H; Fang L; Wang X; Cai J; Mao W
    Mol Clin Oncol; 2014 Sep; 2(5):805-810. PubMed ID: 25054049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.